Dragonfly Therapeutics, Inc.?has licensed two TriNKET?immunotherapy drug candidates to?Celgene Corp. and its affiliates for?$12 million?each plus milestones and royalties.?
Genentech is the latest biopharma company to be involved in an industrial espionage case, with three former researchers accused of passing sensitive information to a foreign rival.
Intellectual Property (IP) could be considered the foundation for pharmaceutical innovation. In healthcare, innovation means improved health outcomes: avoiding illness; slowing disease progression; improving patients’ lives; and reducing overall costs for